CATO 佳途CATO · CNAS + ANAB ISO 17034 双体系认可标准物质生产者CNAS + ANAB ISO 17034 dual-accredited reference material producer
销售顾问Sales contact 卢振明Kaka Lu+86 185 2048 1969kaka@cato-chem.com
Roxithromycin

罗红霉素 杂质对照品Roxithromycin Impurities

EP31 个杂质条目31 impurity entries

本页汇总 罗红霉素 的 31 个杂质对照品条目,其中药典杂质标注了 EP/USP 编号。杂质谱是仿制药杂质研究、方法开发与稳定性考察的起点——先锁定品种,再逐条比对结构差异与保留行为。This page collects 31 impurity reference standards of Roxithromycin with EP/USP numbering where applicable. The impurity profile is the starting point for related-substance method development, forced degradation and stability studies.

批量索取报价 / COABulk quote / COA在全站目录中检索Search the full catalogue

相关研究文献Related literature

以下为 罗红霉素(Roxithromycin)在公开文献中的研究报道(题录信息,来源 PubMed),供方法开发与文献调研参考。Selected peer-reviewed publications on this drug substance — bibliographic records from PubMed.

  1. 杂质研究Impurity studiesSimultaneous degradation of roxithromycin and nitrogen removal by Acinetobacter pittii TR1: Performances, pathways, and mechanisms
    Journal of environmental management · 2025 · Chen X et al.  ·  PMID 39765062  ·  DOI
  2. 杂质研究Impurity studiesCharacterization of two unknown impurities in roxithromycin by 2D LC-QTOF/MS/MS and NMR
    Journal of pharmaceutical and biomedical analysis · 2020 · Wang J et al.  ·  PMID 32113121  ·  DOI
  3. 杂质研究Impurity studiesLiquid chromatographic determination of roxithromycin: application to stability studies
    Journal of chromatographic science · 2013 · Wahba ME  ·  PMID 22718747  ·  DOI
  4. 分析方法Analytical MethodsSimultaneous determination of roxithromycin and ambroxol hydrochloride in a new tablet formulation by liquid chromatography
    Journal of pharmaceutical and biomedical analysis · 2004 · Qi M et al.  ·  PMID 15336374  ·  DOI
  5. 分析方法Analytical MethodsDetermination of roxithromycin from human plasma samples based on magnetic surface molecularly imprinted polymers followed by liquid chromatography-tandem mass spectromer
    Journal of chromatography. B, Analytical technologies in the biomedical and life sciences · 2016 · Ding J et al.  ·  PMID 26300321  ·  DOI

罗红霉素 —— 原料药与杂质对照品Roxithromycin — drug substance & impurities

共 32 个条目(含原料药本体)32 items incl. the drug substance
Roxithromycin structure
EP原料药 APIAPI
罗红霉素Roxithromycin
Roxithromycin
CAS No.80214-83-1
Chemical FormulaC41H76N2O15
Purity>95%询价On request
10mg25mg50mg100mg
Roxithromycin Impurity 1(Roxithromycin EP Impurity A) structure
EPA
罗红霉素杂质1(罗红霉素EP杂质A)Roxithromycin Impurity 1(Roxithromycin EP Impurity A)
Roxithromycin Impurity 1(Roxithromycin EP Impurity A)
CAS No.114-07-8
Chemical FormulaC37H67NO13
Purity>95%询价On request
10mg25mg50mg100mg
Roxithromycin Impurity 2(Roxithromycin EP Impurity B) structure
EPB
罗红霉素杂质2(罗红霉素EP杂质B)Roxithromycin Impurity 2(Roxithromycin EP Impurity B)
Roxithromycin Impurity 2(Roxithromycin EP Impurity B)
CAS No.214902-82-6
Chemical FormulaC33H62N2O12
Purity>95%询价On request
10mg25mg50mg100mg
Roxithromycin Impurity 3(Roxithromycin EP Impurity C) structure
EPC
罗红霉素杂质3(罗红霉素EP杂质C)Roxithromycin Impurity 3(Roxithromycin EP Impurity C)
Roxithromycin Impurity 3(Roxithromycin EP Impurity C)
CAS No.111321-02-9
Chemical FormulaC37H68N2O13
Purity>95%询价On request
10mg25mg50mg100mg
Roxithromycin Impurity 3 Hydrochloride(Roxithromycin EP Impurity C Hydrochloride) structure
EPC
罗红霉素杂质3 盐酸盐(罗红霉素EP杂质C 盐酸盐)Roxithromycin Impurity 3 Hydrochloride(Roxithromycin EP Impurity C Hydrochloride)
Roxithromycin Impurity 3 Hydrochloride(Roxithromycin EP Impurity C Hydrochloride)
CAS No.145645-54-1
Chemical FormulaC37H68N2O13·HCl
Purity>95%询价On request
10mg25mg50mg100mg
Roxithromycin Impurity 4(Roxithromycin EP Impurity D) structure
EPD
罗红霉素杂质4(罗红霉素EP杂质D)Roxithromycin Impurity 4(Roxithromycin EP Impurity D)
Roxithromycin Impurity 4(Roxithromycin EP Impurity D)
CAS No.134931-00-3
Chemical FormulaC41H76N2O15
Purity>95%询价On request
10mg25mg50mg100mg
Roxithromycin Impurity 5 (Roxithromycin EP Impurity E) structure
EPE
罗红霉素杂质5 (罗红霉素EP杂质E)Roxithromycin Impurity 5 (Roxithromycin EP Impurity E)
Roxithromycin Impurity 5 (Roxithromycin EP Impurity E)
CAS No.1460313-66-9
Chemical FormulaC40H74N2O15
Purity>95%询价On request
10mg25mg50mg100mg
Roxithromycin Impurity 6(Roxithromycin EP Impurity F) structure
EPF
罗红霉素杂质6(罗红霉素EP杂质F)Roxithromycin Impurity 6(Roxithromycin EP Impurity F)
Roxithromycin Impurity 6(Roxithromycin EP Impurity F)
CAS No.118267-18-8
Chemical FormulaC40H74N2O15
Purity>95%询价On request
10mg25mg50mg100mg
Roxithromycin Impurity 7(Roxithromycin EP Impurity G) structure
EPG
罗红霉素杂质7(罗红霉素EP杂质G)Roxithromycin Impurity 7(Roxithromycin EP Impurity G)
Roxithromycin Impurity 7(Roxithromycin EP Impurity G)
CAS No.425365-64-6
Chemical FormulaC42H78N2O16
Purity>95%询价On request
10mg25mg50mg100mg
Roxithromycin Impurity 8(Roxithromycin EP Impurity H) structure
EPH
罗红霉素杂质8(罗红霉素EP杂质H)Roxithromycin Impurity 8(Roxithromycin EP Impurity H)
Roxithromycin Impurity 8(Roxithromycin EP Impurity H)
CAS No.425365-65-7
Chemical FormulaC41H76N2O14
Purity>95%询价On request
10mg25mg50mg100mg
Roxithromycin Impurity 9 (Roxithromycin EP Impurity I) structure
EPI
罗红霉素杂质9 (罗红霉素EP杂质I)Roxithromycin Impurity 9 (Roxithromycin EP Impurity I)
Roxithromycin Impurity 9 (Roxithromycin EP Impurity I)
CAS No.425365-66-8
Chemical FormulaC45H84N2O17
Purity>95%询价On request
10mg25mg50mg100mg
Roxithromycin Impurity 10 (Roxithromycin EP Impurity J) structure
EPJ
罗红霉素杂质10 (罗红霉素EP杂质J)Roxithromycin Impurity 10 (Roxithromycin EP Impurity J)
Roxithromycin Impurity 10 (Roxithromycin EP Impurity J)
CAS No.134834-12-1
Chemical FormulaC40H73ClN2O14
Purity>95%询价On request
10mg25mg50mg100mg
Roxithromycin Impurity 4-d7(Roxithromycin EP Impurity D-d7) structure
EPD-D7
罗红霉素杂质4-d7(罗红霉素EP杂质D-d7)Roxithromycin Impurity 4-d7(Roxithromycin EP Impurity D-d7)
Roxithromycin Impurity 4-d7(Roxithromycin EP Impurity D-d7)
CAS No.2253707-77-4
Chemical FormulaC41H69D7N2O15
Purity>95%询价On request
Roxithromycin Impurity 12 (N-Oxide Roxithromycin) structure
12
罗红霉素杂质12 (罗红霉素氮氧化物)Roxithromycin Impurity 12 (N-Oxide Roxithromycin)
Roxithromycin Impurity 12 (N-Oxide Roxithromycin)
CAS No.1460313-73-8
Chemical FormulaC41H76N2O16
Purity>95%询价On request
10mg25mg50mg100mg
Roxithromycin Impurity 14 structure
14
罗红霉素杂质14Roxithromycin Impurity 14
Roxithromycin Impurity 14
CAS No.1460313-65-8
Chemical FormulaC41H76N2O16
Purity>95%询价On request
10mg25mg50mg100mg
Roxithromycin Impurity 15 structure
15
罗红霉素杂质15Roxithromycin Impurity 15
Roxithromycin Impurity 15
CAS No.3970-21-6
Chemical FormulaC4H9ClO2
Purity>95%询价On request
10mg25mg50mg100mg
Roxithromycin Impurity 16 structure
16
罗红霉素杂质16Roxithromycin Impurity 16
Roxithromycin Impurity 16
CAS No.1540576-88-2
Chemical FormulaC6H13ClO2
Purity>95%询价On request
10mg25mg50mg100mg
Roxithromycin Impurity 18 structure
18
罗红霉素杂质18Roxithromycin Impurity 18
Roxithromycin Impurity 18
CAS No.67796-27-4
Chemical FormulaC4H10O3
Purity>95%询价On request
10mg25mg50mg100mg
Roxithromycin Impurity 19 structure
19
罗红霉素杂质19Roxithromycin Impurity 19
Roxithromycin Impurity 19
CAS No.261172-58-1
Chemical FormulaC40H74N2O15
Purity>95%询价On request
10mg25mg50mg100mg
Roxithromycin Impurity 20 structure
20
罗红霉素杂质20Roxithromycin Impurity 20
Roxithromycin Impurity 20
CAS No.51820-81-6
Chemical FormulaC37H68N2O12
Purity>95%询价On request
10mg25mg50mg100mg
Roxithromycin Impurity 21 structure
21
罗红霉素杂质21Roxithromycin Impurity 21
Roxithromycin Impurity 21
CAS No.51830-04-7
Chemical FormulaC37H68N2O12
Purity>95%询价On request
10mg25mg50mg100mg
Roxithromycin Impurity 22 structure
22
罗红霉素杂质22Roxithromycin Impurity 22
Roxithromycin Impurity 22
CAS No.1460313-67-0
Chemical FormulaC41H74N2O16
Purity>95%询价On request
10mg25mg50mg100mg
Roxithromycin Impurity 26 structure
26
罗红霉素杂质26Roxithromycin Impurity 26
Roxithromycin Impurity 26
CAS No.89268-03-1
Chemical FormulaC5H11ClO3
Purity>95%询价On request
10mg25mg50mg100mg
Roxithromycin Impurity 27 structure
27
罗红霉素杂质27Roxithromycin Impurity 27
Roxithromycin Impurity 27
CAS No.4431-83-8
Chemical FormulaC7H16O4
Purity>95%询价On request
10mg25mg50mg100mg
Roxithromycin Impurity 28 structure
28
罗红霉素杂质28Roxithromycin Impurity 28
Roxithromycin Impurity 28
CAS No.224054-07-3
Chemical FormulaC3H7ClO2
Purity>95%询价On request
10mg25mg50mg100mg
Roxithromycin Impurity 30 structure
30
罗红霉素杂质30Roxithromycin Impurity 30
Roxithromycin Impurity 30
CAS No.1094780-37-6
Chemical FormulaC41H74N2O16
Purity>95%询价On request
10mg25mg50mg100mg
Roxithromycin Impurity 32 structure
32
罗红霉素杂质32Roxithromycin Impurity 32
Roxithromycin Impurity 32
CAS No.134834-10-9
Chemical FormulaC39H72N2O14
Purity>95%询价On request
10mg25mg50mg100mg
Roxithromycin Impurity 33 structure
33
罗红霉素杂质33Roxithromycin Impurity 33
Roxithromycin Impurity 33
CAS No.41771-35-1
Chemical FormulaC6H13ClO2
Purity>95%询价On request
10mg25mg50mg100mg
Roxithromycin Impurity 34 structure
34
罗红霉素杂质34Roxithromycin Impurity 34
Roxithromycin Impurity 34
CAS No.74498-88-7
Chemical FormulaC5H12O3
Purity>95%询价On request
10mg25mg50mg100mg
Roxithromycin Impurity 38 structure
38
罗红霉素杂质38Roxithromycin Impurity 38
Roxithromycin Impurity 38
CAS No.121256-15-3
Chemical FormulaC36H66N2O13
Purity>95%询价On request
10mg25mg50mg100mg
Roxithromycin Impurity 44 structure
44
罗红霉素杂质44Roxithromycin Impurity 44
Roxithromycin Impurity 44
CAS No.305831-46-3
Chemical FormulaC41H76N2O15·C12H22O12
Purity>95%询价On request
10mg25mg50mg100mg
Roxithromycin Impurity 45 structure
45
罗红霉素杂质45Roxithromycin Impurity 45
Roxithromycin Impurity 45
CAS No.53317-21-8
Chemical FormulaC37H68N2O14
Purity>95%询价On request
10mg25mg50mg100mg

结构式清晰度以随货 COA 与厂家图谱为准;目录之外的杂质可按需定制合成或调取。Structural confirmation is governed by the COA and manufacturer spectra. Impurities outside this list can be custom-synthesised or sourced on request.

Literature & synthesis

罗红霉素 —— 研究文献与合成路线Roxithromycin — literature & synthetic routes

以下题录由公开学术数据库按品种名检索汇总,供 罗红霉素 的杂质谱研究、分析方法开发与工艺路线选择参考。文献题名与专利标题均可点击查看原文,版权归原作者与出版方所有。Citations below are aggregated from public scholarly databases by drug-substance name, for reference in impurity profiling, analytical method development and route selection for Roxithromycin. Titles link to the original records; copyright remains with the authors and publishers.

杂质与降解研究文献Impurity & degradation studies

  1. Phototransformation of roxithromycin in the presence of dissolved organic matter: Characteriazation of the degradation products and toxicity evaluation
    Li W, Lyu B, Li J, et al. · The Science of the total environment · 2020 · 被引 17cited 17
  2. Degradation of typical macrolide antibiotic roxithromycin by hydroxyl radical: kinetics, products, and toxicity assessment
    Li W, Xu X, Lyu B, et al. · Environmental science and pollution research international · 2019 · 被引 14cited 14
  3. Simultaneous degradation of roxithromycin and nitrogen removal by Acinetobacter pittii TR1: Performances, pathways, and mechanisms
    Chen X, Yu M, Song G, et al. · Journal of environmental management · 2025 · 被引 1cited 1
  4. Characterization of two unknown impurities in roxithromycin by 2D LC-QTOF/MS/MS and NMR
    Wang J, Zhou J, Xu Y, et al. · Journal of pharmaceutical and biomedical analysis · 2020 · 被引 2cited 2
  5. Simultaneous determination of roxithromycin and ambroxol hydrochloride in a new tablet formulation by liquid chromatography
    Qi M, Wang P, Cong R, et al. · Journal of pharmaceutical and biomedical analysis · 2004 · 被引 18cited 18
  6. Roxithromycin potency quantification in pharmaceutical preparation by applying a validated bioassay method and comparison with HPLC analysis
    Suke SG, Chahande AD, Kasliwal RH, et al. · Annales pharmaceutiques francaises · 2015 · 被引 6cited 6

合成与制备工艺专利Synthesis & process patents

  1. A process for the purification of roxithromycin
    Mistry Dhirenkumar N. Alembic Limited, Thorat Mahadeo M. Alembic Limited, Soni Kamlesh S. Alembic Limited, Mishra Rakesh R. Alembic Limited, et al. · 公开号 EP1435359EP1435359 · 2004
  2. Ophthalmic preparation containing roxithromycin
    YANG SHILIN · 公开号 CN1628688CN1628688 · 2005
  3. A process for the purification of roxithromycin
    THORAT MAHADEO M, MISTRY DHIRENKUMAR N, KANSAL VINOD KUMAR, MISHRA RAKESH R, et al. · 公开号 AU2003271408AU2003271408 · 2004
  4. Roxithromycin derivate and its preparation method and medical application
    WANG QINGLI · 公开号 CN1955187CN1955187 · 2007
  5. Lung-targeting roxithromycin microsphere for animal and birds and its preparing method
    LI XUDONG BAO · 公开号 CN1985839CN1985839 · 2007

题录与链接来自公开数据库 Europe PMC(含 PubMed 与全球专利题录)与 WIPO PatentScope,本站仅提供索引,不转载正文;如链接失效请以数据库检索为准。Citations are indexed from public databases (Europe PMC incl. PubMed and patent records, WIPO PatentScope); we provide links only and do not reproduce full text.

For formulation & analytical R&D

罗红霉素 杂质谱研究要点Roxithromycin — impurity profiling notes

下面这些是拿到 罗红霉素 的 32 个杂质条目之后,仿制药研发最常遇到的几件事。先把杂质的来源分清,再决定要不要买对照品、买哪几个。Once you have the 32 impurity entries for Roxithromycin, these are the questions that come up most in generic development. Classify the source of each impurity first, then decide which reference standards you actually need.

01工艺杂质Process impurities

起始物料、中间体、副产物、催化剂与溶剂残留。多来自合成路线本身,应在工艺开发阶段用加标试验定位。Starting materials, intermediates, by-products, catalysts and residual solvents — traced back to the synthetic route and located with spiking studies during process development.

02降解杂质Degradation impurities

水解、氧化、光解、高温高湿与聚合产物。需通过强制降解试验识别,并确认方法具备稳定性指示能力。Hydrolytic, oxidative, photolytic, thermal and polymeric degradants — identified through forced degradation, with the method proven stability-indicating.

03药典杂质Pharmacopoeial impurities

EP/USP 已收载并有官方编号的杂质(如 EP Impurity A、USP Related Compound B)。申报时通常需逐项对照。Impurities already monographed with official designations (e.g. EP Impurity A, USP Related Compound B), normally compared item by item during filing.

04基因毒性杂质Genotoxic impurities

含警示结构、需按 ICH M7 进行危害评估与限度推导(TTC 1.5 µg/日)。该类杂质必须用对照品准确控制。Structurally alerting compounds requiring ICH M7 hazard assessment and limit derivation (TTC 1.5 µg/day); these must be controlled with an authentic reference standard.

05同位素标记物Isotopically labelled standards

氘代、¹³C、¹⁵N 标记的同类物,主要用作 LC-MS/MS 生物分析的内标,抵消基质效应与回收率波动。Deuterated, ¹³C- and ¹⁵N-labelled analogues used as internal standards in LC-MS/MS bioanalysis to compensate matrix effects and recovery variation.

06代谢与转化产物Metabolites & conversion products

体内代谢物、强制降解转化物与工艺中间态,常见于杂质谱比对与稳定性考察中。In-vivo metabolites, forced-degradation products and process intermediates encountered in impurity profiling and stability studies.

本品种含药典编号杂质(EP/USP)。申报时药典已收载的杂质通常需要逐项对照,建议优先备齐药典编号对照品,再补充工艺与降解杂质。This drug substance includes pharmacopoeially designated impurities (EP/USP). Monographed impurities normally need item-by-item comparison during filing, so secure the pharmacopoeial standards first, then fill in process and degradation impurities.

方法开发与对照品使用建议Method development and standards usage

先定分离,再谈定量Resolution first, then quantification

主成分与相邻杂质峰分离度应 ≥1.5;用杂质对照品确定相对保留时间与相对响应因子,避免用自身对照法掩盖响应差异。Target baseline resolution ≥1.5 between the main component and adjacent impurities; establish relative retention and relative response factors with authentic impurity standards rather than relying on self-comparison.

校正因子不可忽略Never ignore response factors

紫外吸收差异大的杂质必须校正,否则定量结果系统性偏低或偏高。EP/USP 已给出校正因子的按药典执行。Impurities with markedly different UV response need correction, otherwise results are systematically biased. Where EP/USP publish a correction factor, follow the monograph.

强制降解要做全Run the full forced-degradation panel

建议覆盖酸、碱、氧化(H₂O₂)、光照(ICH Q1B)、高温高湿;主峰纯度用二极管阵列或质谱确认。Cover acid, base, peroxide oxidation, photostability (ICH Q1B) and heat/humidity; confirm peak purity by DAD or MS.

定义报告阈值Set reporting and identification thresholds

按 ICH Q3A/Q3B 设定报告阈值、鉴定阈值与界定阈值,避免为无意义的峰投入过多工作量。Apply ICH Q3A/Q3B reporting, identification and qualification thresholds so effort is not spent on insignificant peaks.

标准品储存有讲究Store standards properly

杂质对照品多建议 −20 ℃ 避光、干燥、密封保存;溶液现配现用,并记录开瓶与配制日期。Most impurity standards should be stored at −20 °C, protected from light and moisture; prepare solutions fresh and record opening and preparation dates.

用结构式先做初判Start from the structure

先比对杂质与主成分的结构差异,可预判其保留行为、紫外响应与可能的降解路径,能显著减少试错。Comparing the impurity structure with the parent drug predicts retention behaviour, UV response and probable degradation routes, cutting trial and error.

以上为通行的杂质研究实践提示,不针对具体品种给出结论。实际限度、校正因子与色谱条件请以 EP/USP 各论及你们的验证数据为准。需要某个杂质的结构确证资料、COA 或定制合成,可直接联系我们。The above are general impurity-profiling notes and are not conclusions about this specific drug substance. Actual limits, correction factors and chromatographic conditions follow the EP/USP monograph and your own validation data. Contact us for structural confirmation data, COAs or custom synthesis.
索取杂质谱报价 / COARequest a quote / COA← 查看其它品种← Other drug substances